Heart Failure Clinical Trial

Expansion of Abbreviations and Acronyms for Patients

Summary

This is a prospective, two-arm, parallel, individually randomized controlled trial to estimate the effect of expansion on patient comprehension (primary outcome) of abbreviations and acronyms in their health records. English-speaking adult patients with diagnosed heart failure who receive primary care at three urban hospitals in New York City will be considered. The investigators hypothesize that expansion will significantly increase patient comprehension of abbreviations and acronyms in the health record.

View Full Description

Full Description

Importance: In 2020, an estimated 100 million Americans accessed their own health records online. That number likely increased beginning April 2021, when U.S. federal rules implemented the 21st Century Cures Act requiring electronic health information to be made freely accessible. Medical abbreviations and acronyms may limit patient understanding of health records. Automated expansion is one potential solution, however, the magnitude of its effect on patient comprehension has not been estimated.

Objective: To estimate the effect of expansion on patient comprehension of abbreviations and acronyms in their health records.

Design: Prospective, two-arm, parallel, individually randomized controlled trial.

Participants: Patients who receive primary care at one of three urban hospitals. A purposive sample representative on age, gender, and race will be enrolled between February 2020 and August 2021. To isolate the main effect, the investigators will include only English-speaking adult patients with diagnosed heart failure.

Intervention: Participants will be randomized to receive clinical text with abbreviations (control group, n=30) or with expansions (intervention group, n=30). The abbreviations and expansions included "hrs" (hours), "MD" (medical doctor), "BP" (blood pressure), "ED" (emergency department), "yo" (year old), "pt" (patient), "HF" (heart failure), "hx" (history), "HTN" (hypertension), "MI" (myocardial infarction).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Adult (21 years or older)
Confirmed diagnosis of heart failure
Able to read and speak English
Willing and able to provide informed consent
Receives primary care from participating provider

Exclusion Criteria:

Healthcare professional (MD, DO, RN, etc.)
No telephone number or email address
Severe cognitive impairment or clinical diagnosis of dementia
Major psychiatric illness, including active psychosis
Other illness that would preclude participation

Study is for people with:

Heart Failure

Estimated Enrollment:

60

Study ID:

NCT05297942

Recruitment Status:

Completed

Sponsor:

Weill Medical College of Cornell University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Weill Cornell Medicine
New York New York, 10065, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

60

Study ID:

NCT05297942

Recruitment Status:

Completed

Sponsor:


Weill Medical College of Cornell University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider